glp-1 + nad Microdosing GLP-1 and NAD+ - Precision

Bloodwork & live consult required

Tirzepatide, a dual GIP and GLP-1 receptor agonist approved for type 2 diabetes and chronic weight management, commonly causes gastrointestinal effects including nausea, diarrhea, and constipation

That is the practical payoff of a real small molecule

Compounders working under traditional 503A authority (patient-specific clinical need) continue to operate legally in 2026

Boost Your Energy If youre dealing with unexplained fatigue, burnout, or just not feeling your best, it might be time to address what your body is missing

Most GLP1 side effects are GI-related (nausea, constipation) and improve as your body adjusts